ATC Group: P02BX04 Triclabendazole

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of P02BX04 in the ATC hierarchy

Level Code Title
1 P Antiparasitic products, insecticides and repellents
2 P02 Anthelmintics
3 P02B Antitrematodals
4 P02BX Other antitrematodal agents
5 P02BX04 Triclabendazole

Active ingredients in P02BX04

Active Ingredient Description
Triclabendazole

Triclabendazole is an anthelmintic against Fasciola species, used for the treatment of fascioliasis.

Related product monographs

Title Information Source Document Type  
EGATEN Tablet FDA, National Drug Code (US) MPI, US: SPL/PLR

Medicines in this ATC group

United States (US)

France (FR)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.